0 التعليقات
0 المشاركات
1كيلو بايت مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Lurbinectedin Market Size, Share, Cancer Therapeutics Innovation & Oncology Drug Development Trends | Industry Forecast to 2029The Lurbinectedin Market has emerged as a notable niche within the oncology therapeutics landscape, driven by advancements in targeted cancer treatments and rising incidence of small cell lung cancer (SCLC) and select solid tumors. The lurbinectedin market is expected to witness market growth at a rate of 45.30% in the forecast period of 2022 to...0 التعليقات 0 المشاركات 553 مشاهدة 0 معاينة
-
Osteosarcoma Market: Drug Development Pipeline, Chemotherapy and Targeted Therapy Analysis, and Orthopedic Oncology LandscapeExecutive Summary: The Global Osteosarcoma Treatment Market is a specialized sector within oncology, focused on the most common primary bone cancer, predominantly affecting children and young adults. The market is defined by a high unmet need, as the standard-of-care (chemotherapy and surgery) has seen limited survival improvements in decades. Growth is primarily fueled by the advancing...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Emerging Trends Influencing the Antibody Drug Conjugates MarketAsia-Pacific is expected to witness rapid growth in the coming years due to increasing healthcare investments and expanding pharmaceutical manufacturing capabilities. Countries like China and India are emerging as important research hubs. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...0 التعليقات 0 المشاركات 3كيلو بايت مشاهدة 0 معاينة
-
Future Market Potential of Chemotherapy-Induced Peripheral Neuropathy TreatmentsThe global chemotherapy-induced peripheral neuropathy market size is projected to grow from US$ 1.01 billion in 2025 to approximately US$ 1.67 billion by 2034, reflecting a steady expansion. The market is anticipated to register a compound annual growth rate (CAGR) of around 5.71% during the forecast period, highlighting increasing investments in oncology supportive care. The...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Global High Potent API (HPAPI) Market — Trends and Market Leaders & Key Company ProfilesThe global high potent API (HPAPI) market is experiencing exceptional growth momentum, driven by the surging demand for targeted cancer therapies, rapid advancements in containment and manufacturing technologies, and a structural shift toward outsourced pharmaceutical production. According to The Insight Partners, the high potent API market was valued at US$ 28.82 Billion in...0 التعليقات 0 المشاركات 474 مشاهدة 0 معاينة
-
How Cancer Treatment Demand Is Expanding the Asia-Pacific Taxane MarketExecutive Summary Asia-Pacific Taxane Market Size and Share: Global Industry Snapshot CAGR Value Asia-Pacific taxane market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.7% in the forecast period of 2022 to 2029. The research and analysis carried out in this Asia-Pacific...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Immunotherapy Impact on the Anti-cancer Drugs MarketThe rapid growth of the biotechnology sector is supporting breakthroughs in anti-cancer drug development. Researchers are leveraging advanced technologies such as gene therapy and cell-based therapies. These innovations are opening new possibilities in cancer treatment. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 التعليقات 0 المشاركات 706 مشاهدة 0 معاينة
-
Why the Azacitidine Market Holds Promise for Advanced Cancer and Blood Disorder Treatments?Executive Summary Azacitidine Market: Share, Size & Strategic Insights CAGR Value The global azacitidine market was valued at USD 90.24 billion in 2024 and is expected to reach USD 165.79 billion by 2032During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.90%, primarily driven by increasing geriatric population Azacitidine Market report is...0 التعليقات 0 المشاركات 3كيلو بايت مشاهدة 0 معاينة
الصفحات المعززة